SCHEMBL29133706

SCHEMBL29133706

CCC1(Nc2c(C#N)cnc3ccc(-c4cccnc4)cc23)C=CC=CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 8/20 0.40
▸ KCNH2 Q12809 7/20 0.40
▸ DYRK1A Q13627 1/20 0.39
▸ DYRK1B Q9Y463 1/20 0.39
▸ ATR Q13535 6/20 0.38
▸ EGFR P00533 3/20 0.38
▸ PRKDC P78527 2/20 0.38
▸ PIK3CA P42336 1/20 0.38
▸ KDR P35968 2/20 0.38
▸ RIPK2 O43353 1/20 0.38
▸ RET P07949 1/20 0.38
▸ MAPK14 Q16539 1/20 0.38
▸ SRC P12931 3/20 0.38
▸ ABL1 P00519 1/20 0.38
▸ FLT1 P17948 1/20 0.38
▸ SYK P43405 1/20 0.38
▸ CYP1A2 P05177 4/20 0.37
▸ CYP3A4 P08684 4/20 0.37
▸ CLK4 Q9HAZ1 3/20 0.37
▸ HIF1A Q16665 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133737 0.88 MAP4K4 (0.42) DYRK1AEGFRPRKDCPIK3CAKDR
SCHEMBL29133763 0.87 MELK (0.38) EGFRPRKDCPIK3CAKDRSRC
SCHEMBL29133729 0.86 EGFR (0.52) DYRK1ADYRK1BEGFRPRKDCPIK3CA
SCHEMBL29133713 0.85 EGFR (0.44) ATMATREGFRPRKDCPIK3CA
SCHEMBL29133769 0.84 PIK3CA (0.46) KCNH2PIK3CA
SCHEMBL29133758 0.84 EGFR (0.42) DYRK1ADYRK1BEGFRPRKDCPIK3CA
SCHEMBL29133701 0.84 PIK3CA (0.38) ATMKCNH2EGFRPRKDCPIK3CA
SCHEMBL29133718 0.83 MELK (0.49) DYRK1AEGFR
SCHEMBL29133697 0.83 MELK (0.49) EGFRPRKDC
SCHEMBL29133779 0.82 EGFR (0.41) EGFRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 — — CN disclosed
Send feedback